Evidence map›Paper›PMID 37937250›Full record

ReviewADMET & DMPK2023

Eco-friendly synthesis of chitosan and its medical application: from chitin extraction to nanoparticle preparation.

Riyona Desvy Pratiwi, Sjaikhurrizal El Muttaqien, Nunik Gustini, Najla Salsabilla Difa, Gita Syahputra, A'liyatur Rosyidah

Open access · diamondAbstract readReview
In one paragraph

Review in ADMET & DMPK, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Riyona Desvy PratiwiResearch Center for Vaccine and Drug, Organization Research of Health, The National Research and Innovation Agency, Jalan Raya Bogor Km 46 Cibinong, Bogor 16911, West Java, Indonesia.
Sjaikhurrizal El MuttaqienResearch Center for Vaccine and Drug, Organization Research of Health, The National Research and Innovation Agency, Jalan Raya Bogor Km 46 Cibinong, Bogor 16911, West Java, Indonesia.
Nunik GustiniResearch Center for Vaccine and Drug, Organization Research of Health, The National Research and Innovation Agency, Jalan Raya Bogor Km 46 Cibinong, Bogor 16911, West Java, Indonesia.
Najla Salsabilla DifaResearch Center for Vaccine and Drug, Organization Research of Health, The National Research and Innovation Agency, Jalan Raya Bogor Km 46 Cibinong, Bogor 16911, West Java, Indonesia.
Gita SyahputraResearch Center for Vaccine and Drug, Organization Research of Health, The National Research and Innovation Agency, Jalan Raya Bogor Km 46 Cibinong, Bogor 16911, West Java, Indonesia.
A'liyatur RosyidahResearch Center for Vaccine and Drug, Organization Research of Health, The National Research and Innovation Agency, Jalan Raya Bogor Km 46 Cibinong, Bogor 16911, West Java, Indonesia.
Indonesian Agency for Agricultural Research and Development · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Chitosan, a chitin deacetylation product, has been applied in nanoparticle or nano-chitosan for medical applications. However, the chitin extraction from crustacean shells and other natural resources, chitin deacetylation, and crosslinking of the chitosan forming the nano-chitosan mostly involve hazardous chemical and physical processes. The risks of these processes to human health and the environment attract the attention of scientists to develop safer and greener techniques. This review aims to describe the progress of harmless chitosan synthesis. Experimental Approach: All strongly related publications to each section, which were found on scientific search engines (Google Scholar, Scopus, and Pubmed), were studied, selected, and then used as references in writing this review. No limitation for the publication year was applied. The publications were searched from April 2022 - June 2023. Key Results: Nano-chitosan could be synthesized in harmless techniques, including the preparation of the chitosan raw materials and crosslinking the chitosan polymer. Enzymatic processes in shell deproteination in the chitin extraction and deacetylation are preferable to reduce the negative effects of conventional chemical-physical processes. Mild alkalines and deep eutectic solvents also provide similar benefits. In the nano-chitosan synthesis, naturally derived compounds (carrageenan, genipin, and valinin) show potency as safer crosslinkers, besides tripolyphosphate, the most common safe crosslinker. Conclusion: A list of eco-friendly and safer processes in the synthesis of nano-chitosan has been reported in recent years. These findings are suggested for the nano-chitosan synthesis on an industrial scale in the near future.

Indexed as

drug deliverygreen synthesisnano-chitosan

Identifiers

PMID37937250
PMCPMC10626508
OpenAlexW4386984398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.